Genetic analysis for a shared biological basis between migraine and coronary artery disease
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received April 4, 2015
- Accepted in final form May 27, 2015
- First Published July 2, 2015.
Author Disclosures
- Bendik S. Winsvold, MD*,
- Christopher P. Nelson, PhD*,
- Rainer Malik, PhD,
- Padhraig Gormley, PhD,
- Verneri Anttila, PhD,
- Jason Vander Heiden, MSc,
- Katherine S. Elliott, PhD,
- Line M. Jacobsen, PhD,
- Priit Palta, PhD,
- Najaf Amin, PhD,
- Boukje de Vries, PhD,
- Eija Hämäläinen, BS,
- Tobias Freilinger, MD,
- M. Arfan Ikram, MD,
- Thorsten Kessler, MD,
- Markku Koiranen, MS,
- Lannie Ligthart, PhD,
- George McMahon, PhD,
- Linda M. Pedersen, PhD,
- Christina Willenborg, PhD,
- Hong-Hee Won, PhD,
- Jes Olesen, PhD,
- Ville Artto, MD,
- Themistocles L. Assimes, PhD,
- Stefan Blankenberg, MD,
- Dorret I. Boomsma, PhD,
- Lynn Cherkas, PhD,
- George Davey Smith, Dsc,
- Stephen E. Epstein, MD,
- Jeanette Erdmann, PhD,
- Michel D. Ferrari, PhD,
- Hartmut Göbel, PhD,
- Alistair S. Hall, PhD,
- Marjo-Riitta Jarvelin, PhD,
- Mikko Kallela, PhD,
- Jaakko Kaprio, PhD,
- Sekar Kathiresan, MD,
- Terho Lehtimäki, MD,
- Ruth McPherson, PhD,
- Winfried März, PhD,
- Dale R. Nyholt, PhD,
- Christopher J. O'Donnell, MD,
- Lydia Quaye, PhD,
- Daniel J. Rader, MD,
- Olli Raitakari, PhD,
- Robert Roberts, MD,
- Heribert Schunkert, MD,
- Markus Schürks, MD,
- Alexandre F.R. Stewart, PhD,
- Gisela M. Terwindt, PhD,
- Unnur Thorsteinsdottir, PhD,
- Arn M.J.M. van den Maagdenberg, PhD,
- Cornelia van Duijn, PhD,
- Maija Wessman, PhD,
- Tobias Kurth, MD,
- Christian Kubisch, MD,
- Martin Dichgans, MD,
- Daniel I. Chasman, PhD,
- Chris Cotsapas, PhD,
- John-Anker Zwart, MD,
- Nilesh J. Samani, FRCP,
- Aarno Palotie, MD;
- For the CARDIoGRAM Consortium and the International Headache Genetics Consortium
- Bendik S. Winsvold, MD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
The Research Council of Norway, grant no. 231187/F20, (2) the South-Eastern Norway Regional Health Authority (grant number 2010075 and 2011083.
Forsbergs og Aulies legat
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Christopher P. Nelson, PhD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Rainer Malik, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Padhraig Gormley, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Verneri Anttila, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Orion Farmos Research Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Jason Vander Heiden, MSc,
NONE
NONE
Travel funding from New England Biolabs to speak regarding immunoglobulin repertoire sequencing at the 2014 American Society of Human Genetics annual meeting.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
National Library of Medicine, T15 LM07056, 2012-2015.
NONE
United States-Israel Binational Science Foundation grant 2013395.
NONE
NONE
NONE
NONE
NONE
NONE
- Katherine S. Elliott, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Line M. Jacobsen, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
(1) AstraZeneca, Medical Advisor, past 4mnths. Just recently left academia and started in a commercial entity. Not considered relevant to the work of to this article as all my contribution was performed prior to starting in a commercial entity
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Priit Palta, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Personal research grant from the Finnish Cultural Foundation.
NONE
NONE
NONE
NONE
NONE
NONE
- Najaf Amin, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Netherlands Brain Foundation. grant number F2013(1)-28)
NONE
NONE
NONE
NONE
NONE
NONE
- Boukje de Vries, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Eija Hämäläinen, BS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Tobias Freilinger, MD,
NONE
NONE
(1) Speaker honoraria from Boehringer Ingelheim (2) Speaker honoraria from Allergan
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Deutsche Forschungsgemeinschaft (DFG), grant number FR3324/2-1, PI
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- M. Arfan Ikram, MD,
NONE
NONE
(1) Kaizo ltd, speaker honorarium
(1) Neuroepidemiology, Editorial Board Member, 2011-2015, (2) PLoS One, Academic Editor, 2013-2015, (3) Journal of Alzheimer Disease, Academic Editor, 2015
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Janssen Prevention Center
(1) Netherlands Organization for Health Research and Development (ZonMW: 916.13.054)
NONE
(1) the Netherlands Heart Foundation (2009B102 and 2012T008), (2) Internationaal Parkinson Fonds, (3) Internationale Stichting Alzheimer Onderzoek (#12533), (4) Alzheimer Association
NONE
NONE
NONE
NONE
NONE
NONE
- Thorsten Kessler, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Markku Koiranen, MS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lannie Ligthart, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
EFIC-Grünenthal Grant
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- George McMahon, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Linda M. Pedersen, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Christina Willenborg, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Hong-Hee Won, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jes Olesen, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Jannsen Pharmaceutical Products
(1) Allergan
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ville Artto, MD,
NONE
NONE
funding for a trip from (1) Boehringer Ingelheim, ESC, 2007 (2) Orion, 2008, EFNS (3) Menarini, 2008, Migraine trust (4) Bayer, 2009, AAN
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) the Finnish Medical Foundation, 2008 (2) Helsinki University Central Hospital, 2008
NONE
NONE
NONE
NONE
NONE
NONE
- Themistocles L. Assimes, PhD,
NONE
NONE
NONE
Frontiers in Cardiovascular Medicine, Associate Editor
NONE
NONE
NONE
Telomere Diagnostics, Inc.
NONE
NONE
NONE
1) Telomere Diagnostics, Inc.
1) NIDDK, DK088942, PI, 2011-2015 2) NHLBI, HHSN268201300006C, co-PI, 2013-2015
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Stefan Blankenberg, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Dorret I. Boomsma, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lynn Cherkas, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- George Davey Smith, Dsc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Stephen E. Epstein, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
CardioCell For work relating to stem cell therapy for cardiovascular disease
NONE
MedStar Heart and Vascular Institute, MedStar Washington Hospital Center
NONE
CardioCell For work relating to stem cell therapy for cardiovascular disease
NONE
NONE
CardioCell For work relating to stem cell therapy for cardiovascular disease
CardioCell For work relating to stem cell therapy for cardiovascular disease
NONE
- Jeanette Erdmann, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Michel D. Ferrari, PhD,
NONE
NONE
NONE
Cephalalgia, associate editor
NONE
NONE
NONE
(1) Medtronic
NONE
NONE
NONE
NONE
(1) Netherlands Organization for Scientific Research (NWO) (2) European Community (3) ZonMW
NONE
(1) Dutch Heart Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Hartmut Göbel, PhD,
Allergan, Bayer Vital, St. Jude Medical
NONE
Amgen, Allergan, Hormosan, Klosterfrau, MSD, Mundipharma, St. Jude Medical, Teva
Der Schmerz, Pain Research and Treatment
NONE
NONE
NONE
NONE
Allergan, Hormosan, Klosterfrau, MSD, Mundipharma, St. Jude Medical, Teva
NONE
NONE
St. Jude Medical
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Alistair S. Hall, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marjo-Riitta Jarvelin, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Mikko Kallela, PhD,
Advisory Board for MSD (terminated in 2011), Advisory Board for Allergan (terminated in 2013)
NONE
MSD, a scientific meeting, 2009, 2010, 2011 Allergan, a scientific meeting 2011 TEVA, a scientific meeting 2012 Novartis, a scientific meeting 2013 Genzyme, a scientific meeting 2014 Novartis, a scientific meeting 2015
NONE
NONE
NONE
NONE
NONE
NONE
Compensation for producing educational material TEVA (MS educational program) 2012 Allergan (chronic migraine educational program 2013)
NONE
Helsinki University Central Hospital, funded for research, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015
NONE
NONE
NONE
Helsinki Headache Center, hold stock, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015
NONE
NONE
NONE
NONE
NONE
- Jaakko Kaprio, PhD,
D-tect project, PI professor Berit Heitmann, Copenhagen University, non-profit
NONE
1) Pfizer Ltd, speaker honorarium 2012
NONE
NONE
NONE
NONE
Pfizer Ltd, Pharmacogenetics of smoking cessation, 2011-2014
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sekar Kathiresan, MD,
(1) Regeneron (2) Merck (3) Eli Lilly (4) Aegerion (5) Catabasis (6) Amarin (7) Novartis
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Regeneron (2) Aegerion (3) Merck
(1) NIH
NONE
(1) Fondation Leducq
NONE
NONE
NONE
NONE
NONE
NONE
- Terho Lehtimäki, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ruth McPherson, PhD,
NONE
NONE
NONE
Arteriosclerosis, Thrombosis & Vascular Biology, Associate Editor 2008 - present
NONE
NONE
NONE
NONE
Amgen AstraZeneca Johnson & johnson Sanofi
NONE
NONE
NONE
10/2014 – 09/2019. R McPherson, K Rayner, ME Harper, R Dent. Molecular Basis of Weight Loss Variability in Response to Energy Restriction. Canadian Institutes of Health Research #MOP-136936, $170,688 p.a. 04/2014 – 04/2015. R McPherson, K Rayner, ME Harper, R Dent. Molecular Basis of Weight Loss Variability in Response to Energy Restriction. Canadian Institutes of Health Research # OPB – 134211. $100,000 07/2014 – 07/2015. R McPherson: Genotype to phenotype: functional analysis of CHD genetic variants Heart & Stroke Foundation of Canada. BR-7519, $70,000
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Winfried März, PhD,
(1) Aegerion Pharmaceuticals (2) AMGEN (3) Danone Research (4) Sanofi/Genzyme (5) Hoffmann LaRoche (6) MSD (7) Synageva (8) Lilly (9) BASF
NONE
(1) Aegerion Pharmaceuticals (2) AMGEN (3) Danone Research (4) Sanofi/Genzyme (5) Hoffmann LaRoche (6) MSD (7) Synageva (8) Lilly (9) BASF
(1) Europoean Heart Journal (2) Journal of Laboratory Medicine
(!) International application PCT/EP2011/051957 (published as WO 2011/098519) Date of submission: 10.02.2011
NONE
Synlab Services GmbH
see list in 1
see list in 1
NONE
NONE
see list in 1.
(1) European Union (2) German Ministry of Research (3) German Ministry of Commerce (4) Wissenschaftsinitiative Oberrhein
NONE
NONE
Synlab Holding GmbH
NONE
NONE
NONE
Synlab Holding GmbH
NONE
- Dale R. Nyholt, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Christopher J. O'Donnell, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
As an employee of the Division of Intramural Research of the National Heart, Lung and Blood Institute of the US National Institutes of Health, I am a full time employee of the Department of Health and Human Services of the US Government.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lydia Quaye, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Daniel J. Rader, MD,
NONE
NONE
NONE
ATVB, deputy editor
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
National Institutes of Health
NONE
Leducq Fondation
NONE
NONE
NONE
NONE
NONE
NONE
- Olli Raitakari, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Robert Roberts, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Heribert Schunkert, MD,
AstraZeneca, Grant, Honoraria, Constuling Fee, Commercial entity AMGEN, Grant, Honoraria, Constuling Fee, Commercial entity MSD SHARP & DOHME, Grant, Honoraria, Constuling Fee, Commercial enttity
NONE
AstraZeneca, Grant, Consulting Fee, Honoraria, commercial entity Bayer Vital, Grant, Consulting Fee, Honoraria, commercial entity Boehringer Ingelheim, Grant, Consulting Fee, Honoraria, commercial entity Medtronic, Grant, Consulting Fee, Honoraria, commercial entity MSD SHARP & DOHME, Grant, Consulting Fee, Honoraria, commercial entity Novartis, Grant, Consulting Fee, Honoraria, commercial entity Pfizer, Grant, Consulting Fee, Honoraria, commercial entity Sanofi-Aventis, Grant, Consulting Fee, Honoraria, commercial entity St. Jude, Grant, Consulting Fee, Honoraria, commercial entity Boston Scientific, Grant, Consulting Fee, Honoraria, commercial entity Daiichi Sankyo, Grant, Consulting Fee, Honoraria, commercial entity
NONE
NONE
NONE
NONE
AstraZeneca, Grant, Honoraria, Constuling Fee, Commercial enttity AMGEN, Grant, Honoraria, Constuling Fee, Commercial enttity MSD SHARP & DOHME, Grant, Honoraria, Constuling Fee, Commercial enttity
NONE
NONE
NONE
AstraZeneca, Grant, Consulting Fee, Honoraria, commercial entity Bayer Vital, Grant, Consulting Fee, Honoraria, commercial entity Boehringer Ingelheim, Grant, Consulting Fee, Honoraria, commercial entity Medtronic, Grant, Consulting Fee, Honoraria, commercial entity MSD SHARP & DOHME, Grant, Consulting Fee, Honoraria, commercial entity Novartis, Grant, Consulting Fee, Honoraria, commercial entity Pfizer, Grant, Consulting Fee, Honoraria, commercial entity Sanofi-Aventis, Grant, Consulting Fee, Honoraria, commercial entity St. Jude, Grant, Consulting Fee, Honoraria, commercial entity Boston Scientific, Grant, Consulting Fee, Honoraria, commercial entity Daiichi Sankyo, Grant, Consulting Fee, Honoraria, commercial entity
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Markus Schürks, MD,
NONE
NONE
NONE
(1) The Journal of Headache and Pain, Advisory Board member, since 2010, (2) BMC Neurology, Associate Editor, since 2011.
NONE
NONE
(1) Bayer HealthCare Pharmaceuticals, full-time employee, since 2011.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Bayer, 2014-2015
NONE
- Alexandre F.R. Stewart, PhD,
NONE
NONE
NONE
Frontiers in Cardiovascular Medicine - Cardiovascular Genetics (reviewing editor)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Gisela M. Terwindt, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Supported by grants of the Netherlands Organisation for Scientific Research (NWO) (GMT Vidi 917-11-319), and FP7- EUROHEADPAIN-no.602633
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Unnur Thorsteinsdottir, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
I am an employee of deCODE genetics/Amgen
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Arn M.J.M. van den Maagdenberg, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Cornelia van Duijn, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Maija Wessman, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Folkhälsan Research Foundation, Academy of Finland (grant no 139795), Medicinska Understödsföreningen Liv och Hälsa
NONE
NONE
NONE
NONE
NONE
NONE
- Tobias Kurth, MD,
NONE
NONE
NONE
(1) BMJ, consulting clinical epidemiology editor, since 2010. (2) Cephalalgia, associate editor, since 2010.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I have received within the last 2 years investigator- initiated research funding from the French National Research Agency and the University of Bordeaux.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Christian Kubisch, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Martin Dichgans, MD,
NONE
NONE
NONE
(1) Stroke the International Journal of Stroke, editor, (2) Cerebrovascular diseases, editorial board member, (3) Journal of Neurochemistry, editor
NONE
NONE
NONE
(1) Bayer Vital, (2) Boehringer Ingelheim, (3) Bristol- Meyer Squibb, (4) Heel
NONE
NONE
NONE
(1) Wellcometrust, 03/08 following, (2) European Union (EU FP 7), investigator, 10/13-09/16, (3) German Federal Ministry of Education and Research (BMBF), investigator, 12/13-11/16, (4) European Union (EU FP 6), investigator, 03/12-02/15
NONE
NONE
(1) Vascular Dementia Research Foundation, (2) Corona Foundation, (3) Jackstädt Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Daniel I. Chasman, PhD,
NONE
NONE
NONE
Associate editor for Arteriosclerosis, Thrombosis, and Vascular Biology 2009-. No compensation.
NONE
Protein Stucture: Determination, Analysis, and Applications for Drug Discovery. (2003) Chasman ed. Marcel Dekker. New York.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Chris Cotsapas, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NINDS, R01 NS049477, analyst, 2011-2015 NIAID, U01 AI089859, site PI, 2012-2014 NIAID, U19 AI056363, site PI, 2011-2013
NONE
RE Children's Consortium
NONE
NONE
NONE
NONE
NONE
NONE
- John-Anker Zwart, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Nilesh J. Samani, FRCP,
NONE
NONE
NONE
(1) Circulation Cardiovascular Genetics 2009- Editorial Board (2) Heart 2012- Editorial Board
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
British Heart Foundation National Institute for Health Research
NONE
NONE
NONE
NONE
NONE
NONE
- Aarno Palotie, MD;
NONE
NONE
Received travel expenses and/or honoraria for lectures or educational activities not funded by industry
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Finnish Academy, European Union NIH, NINDS
NONE
Juselius Foundation and Finnish Foundation for Cardiovascular Research
NONE
NONE
NONE
NONE
NONE
NONE
- For the CARDIoGRAM Consortium and the International Headache Genetics Consortium
- Correspondence to Dr. Palotie: aarno{at}broadinstitute.org
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.